This opportunity funds confirmatory efficacy clinical trials of both non-pharmacological and pharmacological interventions for mental disorders in adults and children. Trials must align with the experimental therapeutics approach, aiming to increase understanding of disease processes and mechanisms of therapeutic change while addressing unmet therapeutic needs.
Eligible applicants include a wide range of organizations such as independent school districts, public and private higher education institutions, nonprofits, small businesses, tribal governments, and various other entities including federal agencies and foreign organizations.
